Haemonetics Corporation
Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information tech… Read more
Haemonetics Corporation (HAE) - Total Liabilities
Latest total liabilities as of December 2025: $1.58 Billion USD
Based on the latest financial reports, Haemonetics Corporation (HAE) has total liabilities worth $1.58 Billion USD as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Haemonetics Corporation - Total Liabilities Trend (1992–2025)
This chart illustrates how Haemonetics Corporation's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Haemonetics Corporation Competitors by Total Liabilities
The table below lists competitors of Haemonetics Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
China Southern Airlines Company Limited
PINK:CHKIF
|
USA | $284.77 Billion |
|
Youngor Group Co Ltd
SHG:600177
|
China | CN¥30.38 Billion |
|
Reece Limited
OTCGREY:REECF
|
USA | $3.37 Billion |
|
China Oilfield Services Limited
F:CO9
|
Germany | €38.55 Billion |
|
Zydus Lifesciences Limited
NSE:ZYDUSLIFE
|
India | ₹188.07 Billion |
|
Jb Financial
KO:175330
|
Korea | ₩65.24 Trillion |
|
Penske Automotive Group Inc
NYSE:PAG
|
USA | $12.02 Billion |
Liability Composition Analysis (1992–2025)
This chart breaks down Haemonetics Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.75 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.67 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.73 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.63 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Haemonetics Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Haemonetics Corporation (1992–2025)
The table below shows the annual total liabilities of Haemonetics Corporation from 1992 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | $1.63 Billion | +31.93% |
| 2024-03-31 | $1.24 Billion | +10.64% |
| 2023-03-31 | $1.12 Billion | +0.59% |
| 2022-03-31 | $1.11 Billion | +2.03% |
| 2021-03-31 | $1.09 Billion | +60.04% |
| 2020-03-31 | $680.00 Million | +12.05% |
| 2019-03-31 | $606.90 Million | +25.16% |
| 2018-03-31 | $484.91 Million | -2.84% |
| 2017-03-31 | $499.10 Million | -16.42% |
| 2016-03-31 | $597.13 Million | -9.11% |
| 2015-03-31 | $657.00 Million | -3.56% |
| 2014-03-31 | $681.23 Million | -1.65% |
| 2013-03-31 | $692.69 Million | +294.57% |
| 2012-03-31 | $175.56 Million | +19.32% |
| 2011-03-31 | $147.13 Million | -8.63% |
| 2010-03-31 | $161.02 Million | +46.64% |
| 2009-03-31 | $109.81 Million | -4.32% |
| 2008-03-31 | $114.76 Million | +23.28% |
| 2007-03-31 | $93.09 Million | -11.26% |
| 2006-03-31 | $104.89 Million | -6.86% |
| 2005-03-31 | $112.62 Million | -11.77% |
| 2004-03-31 | $127.64 Million | -6.12% |
| 2003-03-31 | $135.97 Million | +6.15% |
| 2002-03-31 | $128.10 Million | -1.31% |
| 2001-03-31 | $129.80 Million | -9.02% |
| 2000-03-31 | $142.67 Million | +6.07% |
| 1999-03-31 | $134.50 Million | -5.28% |
| 1998-03-31 | $142.00 Million | +44.60% |
| 1997-03-31 | $98.20 Million | +38.70% |
| 1996-03-31 | $70.80 Million | -18.90% |
| 1995-03-31 | $87.30 Million | +24.89% |
| 1994-03-31 | $69.90 Million | +30.41% |
| 1993-03-31 | $53.60 Million | -1.11% |
| 1992-03-31 | $54.20 Million | -- |